Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR5A | P47898 | 8/20 | 0.41 |
| ▸ | CREBBP | Q92793 | 3/20 | 0.38 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.35 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 3/20 | 0.34 |
| ▸ | EP300 | Q09472 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18324162 | 1.00 | HTR5A (0.41) | HTR5ACREBBPBRPF1IDO1NOS2 | |
| SCHEMBL18324164 | 1.00 | HTR5A (0.41) | HTR5ACREBBPBRPF1IDO1NOS2 | |
| SCHEMBL29501187 | 1.00 | HTR5A (0.41) | HTR5ACREBBPBRPF1IDO1NOS2 | |
| SCHEMBL7571631 | 1.00 | HTR5A (0.41) | HTR5ACREBBPBRPF1IDO1NOS2 | |
| SCHEMBL19308765 | 1.00 | HTR5A (0.41) | HTR5ACREBBPBRPF1IDO1NOS2 | |
| SCHEMBL7571638 | 1.00 | HTR5A (0.41) | HTR5ACREBBPBRPF1IDO1NOS2 | |
| SCHEMBL18269674 | 1.00 | HTR5A (0.41) | HTR5ACREBBPBRPF1IDO1NOS2 | |
| SCHEMBL18271939 | 1.00 | HTR5A (0.41) | HTR5ACREBBPBRPF1IDO1NOS2 | |
| SCHEMBL3626533 | 0.77 | HTR5A (0.39) | HTR5ACREBBPBRPF1IDO1NOS2 | |
| SCHEMBL28473294 | 0.77 | HTR5A (0.39) | HTR5ACREBBPBRPF1NOS2PBRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-63264567-A | — | — | None | — | — | JP | disclosed |
| EP-4123735-B1 | ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC COMPOUNDS | SFC CO LTD (KR) | 2026-04-01 | — | — | EP | disclosed |
| US-12543493-B2 | Organic light-emitting device | SFC CO., LTD. (KR) | 2026-02-03 | — | — | US | disclosed |
| EP-3885350-B1 | NOVEL BORON COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO LTD (KR) | 2025-09-03 | — | — | EP | disclosed |
| US-20250171420-A1 | MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME | MONTE ROSA THERAPEUTICS AG (CH) | 2025-05-29 | — | — | US | disclosed |
| US-12291543-B2 | Boron compound and organic light-emitting diode comprising same | SFC CO., LTD. (KR) | 2025-05-06 | — | — | US | disclosed |
| EP-4540240-A1 | MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME | Monte Rosa Therapeutics AG (CH) | 2025-04-23 | — | — | EP | disclosed |
| US-20240196736-A1 | ORGANIC LIGHT-EMITTING DEVICE | SFC CO., LTD. (KR) | 2024-06-13 | — | — | US | disclosed |
| EP-4300608-A1 | ORGANIC LIGHT-EMITTING DEVICE | SFC Co., Ltd. (KR) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023244815-A1 | MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME | MONTE ROSA THERAPEUTICS, INC. (US) | 2023-12-21 | — | — | WO | disclosed |
| EP-0363466-A1 | NOVEL COMPOUNDS | BEECHAM GROUP PLC (GB) | 1990-04-18 | — | — | EP | disclosed |
| WO-1989009217-A1 | NOVEL COMPOUNDS | BEECHAM GROUP PLC (GB) | 1989-10-05 | — | — | WO | disclosed |
| US-4871744-A | TREATMENT OF ANXIETY, PSYCHOSIS, MIGRAINS | BEECHAM GROUP P.L.C. (GB) | 1989-10-03 | — | — | US | disclosed |
| JP-S63264567-A | PRODUCTION OF 2,3-DIMETHYLINDOLINE | KAWAKEN FINE CHEM CO LTD | 1988-11-01 | — | — | JP | disclosed |
| US-4741981-A | Photosensitive material for electrophotography contains organic phosphite compounds | RICOH CO., LTD. (JP) | 1988-05-03 | — | — | US | disclosed |
| US-4661428-A | HIGH ENERGY DENSITY; LIGHTWEIGHT SUBSTRATES | RICOH CO., LTD. (JP) | 1987-04-28 | — | — | US | disclosed |
| US-4521504-A | DICHROMATIC IMAGES-CONDUCTIVE SUBSTRATE LAMINATED WITH PHOTOCONDUCTIVE | RICOH COMPANY, LTD. (JP) | 1985-06-04 | — | — | US | disclosed |
| US-4370398-A | Electrostatic copying process | RICOH COMPANY, LTD. (JP) | 1983-01-25 | — | — | US | disclosed |
| US-4361638-A | AMORPHOUS SILICON AND CARBON BASE MATERIAL DOPED WITH HYDROGEN AND FLUORINE | FUJI PHOTO FILM CO., LTD. (JP) | 1982-11-30 | — | — | US | disclosed |
| US-4089853-A | Process for the preparation of cis-5,6-dimethoxy-2-methyl-3-[2-(4-phenyl-1-piperazinyl)-ethyl]indoline | AMERICAN CYANAMID COMPANY (US) | 1978-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12543493-B2 | Organic light-emitting device | CRY1, CRY2, AOC2 | HTR5A 1635/4885CREBBP 4364/4885BRPF1 2360/4885 |
| US-20240196736-A1 | ORGANIC LIGHT-EMITTING DEVICE | AOX1, CRY2, SUN2 | HTR5A 2059/4885CREBBP 3107/4885BRPF1 262/4885 |
| US-20250171420-A1 | MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME | PSMA1, CSNK1G1, CSNK1A1 | HTR5A 4206/4885CREBBP 2136/4885BRPF1 2325/4885 |
| US-12291543-B2 | Boron compound and organic light-emitting diode comprising same | CLTB, CD79B, CYBA | HTR5A 4284/4885CREBBP 4229/4885BRPF1 86/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.